You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Challenges and Opportunities in Overactive Bladder Care: A Framework to Optimize Outcomes

  • Authors: Alan J. Wein, MD, PhD (Hon), FACS; Benjamin M. Brucker, MD; Nitya Abraham, MD; Craig V. Comiter, MD
  • CME / ABIM MOC Released: 9/29/2022
  • Valid for credit through: 9/29/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.75 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for urologists, primary care physicians, and obstetricians/gynecologists.

The goal of this activity is that learners will be better able to remain current on key evidence when making clinical decisions regarding the use of pharmacotherapy in the management of OAB.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Burden of adverse effects associated with anticholinergic therapy in patients with OAB
    • Role of beta-3 adrenergic receptor agonists in the management of OAB
    • Unmet needs surrounding the pharmacoeconomics of medications used to treat OAB
  • Demonstrate greater confidence in their ability to
    • Appropriately manage patients with OAB


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Alan J. Wein, MD, PhD (Hon), FACS

    Professor of Surgery (Urology)
    Emeritus Chief of Urology
    Associate Director, Residency Program in Urology
    University of Pennsylvania
    Philadelphia, Pennsylvania

    Disclosures

    Alan J. Wein, MD, PhD (Hon), FACS , has the following relevant financial relationships:
    Consultant or advisor for: Urovant
    Speaker or member of speakers bureau for: Urovant

  • Benjamin M. Brucker, MD

    Associate Professor
    Director of Urogynecology and Neurourology
    NYU Langone Health
    New York, New York

    Disclosures

    Benjamin M. Brucker, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Anteres; Watkins-Conti
    Speaker or member of speakers bureau for: Allergan; Anteres; Urovant
    Research funding from: AbbVie; Boston Scientific

  • Nitya Abraham, MD

    Associate Professor of Urology
    Co-Director, Pelvic Floor Center
    Montefiore Medical Center
    Bronx, New York

    Disclosures

    Nitya Abraham, MD, has the following relevant financial relationships:
    Speaker or member of speakers bureau for: Urovant (former)

  • Craig V. Comiter, MD

    Professor of Urology
    Professor of Obstetrics and Gynecology
    Stanford University School of Medicine
    Stanford, California

    Disclosures

    Craig V. Comiter, MD, has no relevant financial relationships.

Editor

  • Lisa Cockrell, PhD

    Medical Education Director, Medscape, LLC 

    Disclosures

    Lisa Cockrell, PhD, has no relevant financial relationships. 

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Developed through a partnership between Medscape and National Association of Managed Care Physicians (NAMCP).



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Challenges and Opportunities in Overactive Bladder Care: A Framework to Optimize Outcomes

Authors: Alan J. Wein, MD, PhD (Hon), FACS; Benjamin M. Brucker, MD; Nitya Abraham, MD; Craig V. Comiter, MDFaculty and Disclosures

CME / ABIM MOC Released: 9/29/2022

Valid for credit through: 9/29/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Overview and Burden of Inadequately Controlled OAB

Join here as Dr Wein introduces this program and provides a look at the impact of OAB on patients.
Alan J. Wein, MD, PhD (Hon), FACS

OAB Management Goals: Key Considerations

In this chapter, Dr Brucker reviews current treatment guidelines and the barriers that keep patients from achieving their treatment goals.
Benjamin M. Brucker, MD

Role of the Beta-3 Agonist Class in Personalized OAB Care

Dr Abraham discusses the key clinical data providing evidence for the efficacy and safety of the newest class of agents to treat OAB.
Nitya Abraham, MD

Defining Needs for an Evolving OAB Treatment Algorithm

In this chapter, Dr Comiter summarizes unmet needs and identifies strategies to improve payer and provider collaboration in the management of OAB.
Craig V. Comiter, MD
 

Educational Impact Challenge

The goal of this activity is that learners will be better able to remain current on key evidence when making clinical decisions regarding the use of pharmacotherapy in the management of OAB.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.